Filing Details
Biofrontera Inc. (NASDAQ:BFRI) filed a Form 8-K with the Securities and Exchange Commission on August 13, 2026, disclosing a material event.
8k filedNASDAQ:BFRI
Biofrontera Inc. (BFRI) Reports Material Event to SEC
Biofrontera Inc. (NASDAQ:BFRI) filed a Form 8-K with the Securities and Exchange Commission on August 13, 2026, disclosing a material event.
At publication ·
What changed
Biofrontera Inc. (NASDAQ:BFRI) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Biofrontera Inc. (NASDAQ: BFRI) filed a Form 8-K with the SEC on August 13, 2026, disclosing a material event that shareholders should be aware of.
- The company's stock trades at $1.26 with a market capitalization of $9.4 million.
- The article does not specify the nature of the material event, which could involve leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance.
Market Context
Biofrontera Inc.'s stock currently trades at $1.26 with a market capitalization of $9.4M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Biofrontera Inc.'s stock.
All SEC filings for Biofrontera Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View BFRI Stock Page
Frequently Asked Questions
Where can I read BFRI's SEC filings?
Browse all filings on our BFRI SEC filings page.
What types of SEC filings does Biofrontera Inc. file?
Public companies like Biofrontera Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
